273 related articles for article (PubMed ID: 16079325)
1. Adverse event issue management: what have we learnt from pure red cell aplasia (PRCA)?
Macdougall IC
Nephrol Dial Transplant; 2005 Sep; 20 Suppl 8():viii18-21. PubMed ID: 16079325
[TBL] [Abstract][Full Text] [Related]
2. Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another.
Macdougall IC
Curr Med Res Opin; 2004 Jan; 20(1):83-6. PubMed ID: 14741076
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks.
Macdougall IC
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv9-15. PubMed ID: 15827058
[TBL] [Abstract][Full Text] [Related]
4. Pure red-cell aplasia and epoetin therapy.
Bennett CL; Luminari S; Nissenson AR; Tallman MS; Klinge SA; McWilliams N; McKoy JM; Kim B; Lyons EA; Trifilio SM; Raisch DW; Evens AM; Kuzel TM; Schumock GT; Belknap SM; Locatelli F; Rossert J; Casadevall N
N Engl J Med; 2004 Sep; 351(14):1403-8. PubMed ID: 15459301
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options.
Rossert J; Macdougall I; Casadevall N
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv23-26. PubMed ID: 15827054
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agents].
Rossert J; Casadevall N
Nephrol Ther; 2006 Sep; 2 Suppl 4():S283-6. PubMed ID: 17373271
[TBL] [Abstract][Full Text] [Related]
7. [Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].
Janda K; Kraśniak A; Krzanowski M; Sułowicz W
Przegl Lek; 2010; 67(3):187-91. PubMed ID: 20687383
[TBL] [Abstract][Full Text] [Related]
8. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):481-9. PubMed ID: 15792923
[TBL] [Abstract][Full Text] [Related]
9. [Pure red cell aplasia in erythropoietin therapy in patients with kidney failure].
Opatrný K
Cas Lek Cesk; 2003; 142(12):741-5. PubMed ID: 14746223
[TBL] [Abstract][Full Text] [Related]
10. Prolonged course of pure red cell aplasia after erythropoietin therapy.
Nigg L; Schanz U; Ambühl PM; Fehr J; Bachli EB
Eur J Haematol; 2004 Nov; 73(5):376-9. PubMed ID: 15458518
[TBL] [Abstract][Full Text] [Related]
11. Pure red cell aplasia secondary to treatment with erythropoietin.
Locatelli F; Del Vecchio L
J Nephrol; 2003; 16(4):461-6. PubMed ID: 14696747
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated pure red cell aplasia (PRCA): ensuring future progress by collecting data from a registry.
Aljama P; Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; Martin de Francisco AL
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv27-30. PubMed ID: 15827055
[TBL] [Abstract][Full Text] [Related]
13. [Pure red cell aplasia as a complication of treatment with recombinant human erythropoietin].
Grzegorzewska AE; Sucharzewska-Tomczak M
Pol Merkur Lekarski; 2004 Oct; 17(100):407-9. PubMed ID: 15690716
[TBL] [Abstract][Full Text] [Related]
14. What is antibody-mediated pure red cell aplasia (PRCA)?
Casadevall N
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv3-8. PubMed ID: 15827056
[TBL] [Abstract][Full Text] [Related]
15. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
[TBL] [Abstract][Full Text] [Related]
16. Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia.
Casadevall N; Cournoyer D; Marsh J; Messner H; Pallister C; Parker-Williams J; Rossert J
Eur J Haematol; 2004 Dec; 73(6):389-96. PubMed ID: 15522059
[TBL] [Abstract][Full Text] [Related]
17. Eprex-associated pure red cell aplasia and leachates.
Schellekens H; Jiskoot W
Nat Biotechnol; 2006 Jun; 24(6):613-4. PubMed ID: 16763579
[No Abstract] [Full Text] [Related]
18. Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery.
Boven K; Knight J; Bader F; Rossert J; Eckardt KU; Casadevall N
Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii33-40. PubMed ID: 15824129
[TBL] [Abstract][Full Text] [Related]
19. Immunologic mechanisms of EPO-associated pure red cell aplasia.
Schellekens H
Best Pract Res Clin Haematol; 2005; 18(3):473-80. PubMed ID: 15792922
[TBL] [Abstract][Full Text] [Related]
20. Importance of biologic follow-ons: experience with EPO.
Casadevall N; Rossert J
Best Pract Res Clin Haematol; 2005; 18(3):381-7. PubMed ID: 15792912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
